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Abstract 
Background: Tobacco smoke (TS) toxicity to the brain microvasculature is still an understudied area till date. NF-E2 
related factor (Nrf2) is a key transcription factor responsible for activating the antioxidant response element (ARE) 
genes following an oxidative insult. Till date, several studies targeting the blood brain barrier (BBB) have shown some 
protective role of Nrf2 in ischemia–reperfusion (IR) injury, however, its functional role in chronic smokers subjected to 
a life-long oxidative stress has never been addressed. This is of crucial importance since smokers have a much higher 
risk for cerebrovascular stroke and tobacco smoke exposure has been clearly shown to enhance BBB damage follow-
ing an ischemia/reperfusion injury. Thus, the goal of our study was to investigate the defense pathways activated 
at the BBB endothelial level by TS exposure. Specifically we focused on Nrf2 and nuclear factor kappa-light-chain-
enhancer of activated B signaling response (NF-κβ) as the central protective mechanisms related to oxidative insult.
Results: With the exception of Nicotine, both full flavor (3R4F) and decotinized (ULN) cigarettes activated Nrf2 and 
NFκβ pathways in hCMEC/D3 endothelial cells. Several detoxification and anti-oxidant genes including downstream 
products were also activated including NAD(P)H dehydrogenase quinone 1 (NQO-1), heme oxygenase-1 (HMOX-1), 
catalytic and modifier subunits of glutamate-cysteine ligase (GCL), solute carrier-SLC7A11). Gene expression levels of 
cytochrome P450s (CYP2S1 and CYP51A1) and efflux transporters P-glycoprotein (P-gp) and multi-drug resistance 
protein-4 (MRP4) were also enhanced. Increase of P-gp functional activity and depletion of GSH were also observed. 
Strikingly, toxicity of denicotinized (“reduced exposure”) cigarettes was equivalent to 3R4F (or worse).
Conclusions: This study provides a detailed analysis of Nrf2-related cytoprotective mechanisms activated in 
response to 3R4F and ULN-derived TS exposure correlating the results with their oxidative and inflammatory potential. 
Toxicants present in soluble cigarette smoke extracts (CSE) and not nicotine seem to be the primary determinant of 
vascular toxicity. In this respect our results from this and previous studies suggest that chronic TS exposure can over-
come Nrf2 and NFκB-p65 dependent cytoprotective mechanisms of the brain microvascular endothelium possibly 
leading to BBB impairment and loss of BBB integrity.
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Background
Tobacco smoke (TS) is the leading cause of premature 
preventable death worldwide. Smoking kills nearly 6 
million over the world with 480,000 deaths in United 
States alone [1, 2]. Smoking attributable deaths have 
been largely associated to the pathogenesis of several 
complications such as cancer, ischemic heart disease 
and chronic obstructive pulmonary disease (COPD) [1]. 
However, equally significant but often neglected are the 
effects of chronic smoking on the onset and progression 
of several neurological and neurovascular complica-
tions such as Alzheimer’s disease, multiple sclerosis and 
cerebral stroke [3–5]. Although epidemiological stud-
ies establish cigarette smoking as a major risk factor for 
the onset and progression of these diseases; till date the 
precise mechanisms underlying these irreversible del-
eterious changes to the brain and brain vasculatures are 
poorly understood.
Tobacco smoke consist of several thousand toxic com-
pounds (including nicotine) capable of inducing oxida-
tive stress and vascular inflammation triggering several 
pathophysiological changes in peripheral vasculatures 
[6, 7]. Specifically to the blood brain barrier (BBB); we 
have clearly demonstrated that (1) TS can degrade mem-
brane expression of essential tight junction (TJ) proteins 
such as ZO-1 and occludin; (2) it can induce a vascular 
inflammatory response in BBB endothelial cells (ECs) via 
release of Interleukin-6 (IL-6) and matrix metallopro-
teinase-2 (MMP-2); (3) it can up-regulate vascular adhe-
sion molecules such as vascular adhesion molecule-1 
(VCAM-1) and platelet endothelial cell adhesion mol-
ecule-1 (PECAM-1). All together, the data clearly suggest 
that TS can severely impair and compromise BBB integ-
rity and function [8–10].
Moreover, we have also clearly demonstrated that oxi-
dative stress is one of the cardinal determinants of TS 
induced BBB toxicity where the extent of BBB damage 
positively correlates with the oxidative capacity of the TS 
product tested. Several reduced exposure ‘light’ versions 
of tobacco products are currently available in market that 
claim to be safe solely on the reduction of nicotine or a 
few selected toxicants. Profiling of TS showed a signifi-
cant release of reactive oxygen (ROS), hydrogen peroxide 
content and reactive nitrogen species (RNS) in the nic-
otine-free (NF, “reduced-exposure” brand) and ultralow 
nicotine products along with the full flavor products. As 
the level of tar, H2O2 and nitric oxide content increased; 
TS induced BBB toxicity increased proportionally along 
with the level of pro-inflammatory activity and oxidative 
stress.
Thus we further investigated the role of oxidative stress 
and anti-oxidant mechanisms (such as NF-E2 related 
factor—Nrf2—signaling pathway) activated at the BBB 
endothelium in response to TS exposure. This is one of 
the main protective mechanisms triggered to counteract 
oxidative insult such as those elicited by TS [11].
Although microarray based gene expression studies 
investigating TS induced global changes in cellular tran-
scriptome have been previously reported in human bron-
chial epithelium, oral mucosa and peripheral immune 
cells [12–15]; the effect of TS on BBB endothelium has 
only be marginally addressed and even more so at the 
level of gene expression and transcription. Moreover, 
a comprehensive study focussing on TS activated anti-
oxidant mechanisms at the BBB is still lacking. In this 
study we addressed this critical issue using human BBB 
endothelial cells (hCMEC/D3 cell line) [16] chronically 
exposed to various TS related products over a period of 
24  h. Nrf2 expression and its downstream pathway tar-
gets were also assessed and correlated with respect to 
oxidative and/or inflammatory potential of the specific 
tobacco product.
For this purpose, we performed a side-by-side com-
parative analysis of antioxidant mechanisms triggered 
by nicotine exposure against soluble cigarette smoke 
extracts (CSE) from: (1) regular full flavor cigarette 
(3R4F) and (2) reduced exposure ultra-low nicotine ciga-
rette (ULN). About 43,000 gene targets were screened in 
a microarray based gene expression studies. Positive hits 
from the gene array data were investigated further using 
real time PCR (mRNA) and western blot analysis (pro-
teins expression level) as well as ad hoc functional stud-
ies. In summary, our work provides an in depth detailed 
analysis of the BBB counteractive cellular mechanisms 
triggered by realistic exposure to TS.
Results
CSE increases oxidative stress load and Nrf2 nuclear 
translocation in BBB endothelium
Main and side stream TS contain high levels of toxic 
reactive aldehydes and pro-oxidants that are shown to 
destabilize the cellular redox balance. We assessed the 
impact of TS generated from different tobacco prod-
ucts, on cellular ROS levels (oxidative stress load) in BBB 
endothelium using CellROX® Green Reagent. As shown 
in Figure 1a, exposure to CSE from both full flavor (3R4F) 
and ULN cigarettes rapidly increased endothelial ROS 
(as early as 3 h post-exposure), with greater intensity of 
fluorescence, compared to control. In comparison, expo-
sure to nicotine elicited only a mild oxidative response 
(Figure 1a).
Next, we determined the effects of TS on endothelial 
Nrf2 expression and its nuclear translocation (Figure 1b–
d). Nrf2 is a redox-sensitive transcription factor and 
a master regulator of cellular redox homeostasis. It has 
been demonstrated that increased levels of ROS trigger 
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Figure 1 CSE exposure potentiates oxidative stress responses in BBB endothelial cells. Briefly, confluent hCMEC/D3 cell monolayers were exposed 
to media containing nicotine only (100 μg/mL) or CSEs from full flavor (3R4F) or ULN tobacco products containing nicotine equivalent to 100 ng/
mL). Fresh media without nicotine or mainstream TS served as controls. a Immunofluorescence analysis of cellular ROS levels (an indicator of 
oxidative stress load) were determined by using CellROX® Green reagent following exposure to CSE or nicotine treatment (3 h); b gene array based 
analysis of Nrf2 gene expression changes was determined after control, nicotine or TS exposure (n = 6); c Nrf2 mRNA expression was quantified 
by RT-PCR using primer specific sequences (n = 4); d Nrf2 expression and nuclear translocation following exposure to different conditions at early 
time point of 8 h as analyzed by western blotting. Representative western blots were shown with actin as a loading control. Data were expressed as 
mean ± SEM (fold change over control; n = 4 biological replicates). *p < 0.05 vs. control.
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the activation and subsequent nuclear translocation of 
Nrf2. This ultimately triggers the expression/activation of 
various molecular networks primarily involved in cellular 
cytoprotection against oxidative and inflammatory stress 
[11, 17]. To this end, our data showed modest increase 
in Nrf2 gene expression levels in response to CSE from 
3R4F and ULN cigarettes (Figure  1b). However, Nrf2 
transcription assessed by RT-PCR was significant in BBB 
endothelial cells exposed to ULN-derived CSE (p < 0.05; 
compared to control) but not in cultures exposed to 
CSE derived from 3R4F cigarettes (Figure  1c) Interest-
ingly, Nrf2 nuclear translocation (Figure 1d) was statisti-
cally significant in BBB ECs exposed to either ULN and 
3R4F cigarette extracts. Nicotine exposure did not affect 
Nrf2 gene expression (Figure 1b) nor Nrf2 transcription 
(Figure 1c) or its nuclear translocation (Figure 1d). This 
further supports its relatively modest impact on cellular 
oxidative stress levels observed in Figure 1a.
CSE up‑regulates Nrf2‑ARE dependent phase I 
detoxification genes
As shown in Figure  2a, both microarray and RT-PCR 
analyses revealed a significant induction of NQO1 gene 
(a major enzyme of Phase I detoxification) both by 3R4F 
and ULN products (p  <  0.01 and p  <  0.0001 vs control 
fold change respectively), but not nicotine. Accordingly, 
exposure to 3R4F and ULN upregulated NQO1 protein 
expression as demonstrated by immunofluorescence 
and western blotting (Figure 2b; p < 0.05 and p < 0.01 for 
3R4F and ULN, respectively). Notably, the up-regulation 
of NQO1 expression by ULN was comparable to that 
achieved by 3R4F.
CSE exposure augments transcription of Phase I 
cytochrome P450s detoxification genes
Cytochrome P450 (CYP450) family related enzymes pro-
vide additional layer of counter-regulatory anti-oxidant 
response through metabolism-based detoxification of 
toxic chemicals [18]. Although there is no specific report 
of CYP51A1 with respect to smoke toxicants, CYP2S1 has 
been reported to scavenge xenobiotics especially carcino-
gens present in TS [19]. As shown in Figure 3a, we observed 
a striking up-regulation in the gene expression of the CYP 
enzymes CYP2S1 (Figure 3a, p < 0.001 and p < 0.01 vs. con-
trol, for 3R4F and ULN respectively) which was also con-
firmed by RT-PCR (Figure 3b, p < 0.05 and p < 0.001 vs. 
control for 3R4F and ULN respectively). CYP51A1 gene 
expression was also up-regulated however; the measured 
changes were statistically significant only for BBB endothe-
lial cultures exposed to ULN but not for 3R4F-derived CSE 
(Figure 3a). Corresponding RT-PCR measurements of the 
gene transcription showed only a modest increased but not 
to a significant level in either case. Note also that none of 
the changes in either gene expression or gene transcrip-
tion for both enzymes failed to translate in a correspond-
ing increase in protein expression (see Figure 3c). No effect 
at any level (gene expression, transcription and translation) 
was observed in response to nicotine exposure.
Figure 2 Effects of CSE on Phase I detoxification genes. HCMEC/D3 cells were exposed to nicotine or CSE from different products (see “Methods”). 
Effects of CSE and nicotine on NQO-1 mRNA and protein expression were characterized by: a1 gene array analysis; a2 real-time RT-PCR; b immu-
nofluorescence and western blot analyses of NQO-1 protein. Representative western blots were shown with actin as a loading control. Data were 
expressed as mean ± SEM (fold change over control). *p < 0.05, **p < 0.01, ****p < 0.0001 vs. control. n = 6/biological replicates/condition.
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CSE alters the efflux activity but not the expression of BBB 
P‑glycoprotein
Blood brain barrier endothelial cells are highly enriched 
with polarized expression of ATP-binding cassette super-
family of drug efflux transporters such as P-glycoprotein 
(P-gp) that prevent the brain penetration and accumu-
lation of toxic substances including xenobiotics. Previ-
ous studies have shown that Nrf2 activation induces the 
transcription of major drug efflux transporters [11]. As 
shown in Figure 4, microarray analysis revealed a signifi-
cant up-regulation of two major ABC efflux transporters, 
P-glycoprotein (P-gp; ABCB1) and multidrug resist-
ant protein-4 (MRP-4; ABCC4; p  <  0.05, vs. control) in 
response to 3R4F exposure. The biological effect is con-
sistent with a marked increase in rhodamine123 efflux 
(p  <  0.05, vs. control) used as a measure of P-gp func-
tional activity. CSE from ULN also increased the gene 
expression of P-gp (p < 0.01 vs. control), but not that of 
MRP4 (Figure 4b). However, RT-PCR and western blot-
ting analysis of the cellular membrane fractions did not 
show a corresponding increase in gene transcription and/
or protein expression levels for either of these transport-
ers (Figure 4c). Interestingly, when compared to nicotine, 
TS did produce a statistically significant increase of P-gp 
transcription when compared to nicotine since surpris-
ingly nicotine caused a modest reduction in P-gp tran-
scription when compared to controls.
CSE potentiates synthesis and activity of various 
antioxidants in BBB endothelial cells
The next major component of the Nrf2-ARE pathway is 
the anti-oxidant system. In this study, we compared the 
effects of CSE derived from conventional and reduced 
exposure products on the genes involved in synthesis 
of major anti-oxidant glutathione (GSH), such as glu-
tathione cysteine ligase and SLC7A11 [20]. Genome 
wide transcriptional profiling revealed an amplified gene 
expression of GCL-modifier unit (GCLM) and SLC7A11 
in BBB endothelial cells exposed to CSE from 3R4F and 
ULN (Figure 5a). These results were further validated by 
RT-PCR analysis indicating a potential up-regulation of 
SLC7A11 (Figure  5b, p  <  0.05 and p  <  0.01 vs. control) 
and GCLM transcription (Figure 5c, p < 0.05 vs. control) 
by 3R4F and ULN smoke extracts, respectively. Moreo-
ver, alterations in the protein expression of SLC7A11 and 
GCLM followed a similar trend with significant increase 
upon exposure to CSE derived from both products (Fig-
ure  5b, c). In addition, 3R4F but not ULN moderately 
Figure 3 Effects of CSE on Phase I cytochrome P450s detoxification genes. As mentioned earlier, hCMEC/D3 cell monolayers were exposed to nico-
tine (100 ng/mL) or CSE derived from 3R4F or ULN cigarettes. Following exposure for 24 h, expression of CYPs-CYP2S1 and CYP51A1 was analyzed 
by a DNA microarray, b real time PCR for mRNA; and c protein expression was analyzed by western blotting. Representative western blots were 
shown with actin as a loading control; data were expressed as mean ± SEM (fold change over control). *p < 0.05, **p < 0.01, ***p < 0.001 vs. control. 
n = 6 biological replicates/condition.
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Figure 4 Effects of CSE on ABC efflux transporter expression and functionality in hCMEC/D3 cell line. Cells were exposed to nicotine (100 ng/mL) 
or CSE derived from 3R4F or ULN cigarettes. a P-gp efflux activity was determined by intracellular accumulation of rhodamine123 (a P-gp substrate) 
efflux, as an indirect correlate of P-gp activity n = 3/condition and replicated twice. b Transcriptome analysis of ABC efflux transporters, ABCB1 
(P-gp) and ABCC4 (MRP4) following treatment (n = 6 biological replicates); c RT-PCR analysis of mRNA expression of P-gp and ABCC4 in hCMEC/D3 
cells (n = 6 biological replicates); western blot analysis of transporter protein expression (n = 6 biological replicates). Representative western blots 
were shown with actin as a loading control. Data were expressed as mean ± SEM (fold change over control). *p < 0.05, **p < 0.01, vs. control.
Figure 5 Effects of CSE on GSH based antioxidant system. a Microarray studies revealed an up-regulation in gene expression of two major genes 
involved in GSH synthesis, SLC7A11 and GCLM; b quantitative assessment using real-time PCR and western blot analyses confirm microarray analy-
sis. c mRNA expression of modifier and catalytic subunits of GLC and protein expression of GCLC and GCLM following CSE exposure derived from 
3R4F and ULN products including nicotine. Representative western blots were shown with actin as a loading control; d GSH/GSSG ratio was deter-
mined using Thiol green reagent, as mentioned in the methods section. Data were expressed as mean ± SEM (fold change over control). *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control. n = 6 biological replicates/condition.
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increased gene transcription of GCL-catalytic subunit 
(GCLC), while GCLC protein expression was up-reg-
ulated by both products to a similar extent (Figure  5c). 
By contrast, nicotine did not produced any significant 
alterations in GCLM and SLC7A11 gene expression, 
although we observed a marked increase in the cytoplas-
mic expression of the catalytic and modifier subunits of 
GCL following nicotine exposure, as shown by western 
blotting (Figure 5c). Importantly, all the tested products 
(including nicotine) reduced the turn-over rate of cel-
lular GSH, as demonstrated by the GSH/GSSG ratio 
(Figure 5d, p < 0.05). This clearly suggests a depletion of 
cellular antioxidant protection against incumbent oxida-
tive stress load caused by the exposure to smoke extracts 
and nicotine (in smaller measure).
Continuing on the same path, we assessed the effects 
of nicotine, 3R4F and ULN exposure on gene expres-
sion, transcription and translation of heme oxygenase 
(HMOX-1). HMOX-1 is also a component of the cellular 
antioxidant cytoprotective mechanisms along with other 
molecular networks (including ferritin and pirin involved 
in iron/metal sequestration) [21]. As shown in Figure 6a, 
transcriptome analysis revealed a significant increase in 
the gene expression levels of HMOX-1 and other anti-
oxidant molecules in response to 3R4F and ULN expo-
sure. Results were corroborated by RT-PCR and western 
blot analyses in line with gene expression data as shown 
in Figure 6b, c respectively (p < 0.05, vs. control). Immu-
nofluorescence analysis of the BBB endothelial monolay-
ers further supports these observations (Figure 6d).
CSE increases NF‑κβ expression and nuclear translocation
We next determined the impact of TS and nicotine on 
the p65 subunit of NFκB (NFκB-p65) gene expression, 
a transcriptional factor and potential activator of oxida-
tive and inflammatory stress pathways [22]. As shown 
in Figure  7a1, the mRNA expression of NFκB-p65 was 
markedly elevated by CSE exposure of both products 
with ULN producing a stronger response in 3R4F. We 
also observed a significant increase in the activation 
and nuclear translocation of NFκB-p65 following expo-
sure to either 3R4F or ULN smoke extracts (Figure 7a2). 
Figure 6 Effects of CSE exposure (24 h) on BBB endothelial gene and protein expression of HMOX1. a Several genes belonging to HMOX-1 and 
heme recycling were up-regulated following CSE exposure of TS products. Nicotine did not produce any change in these genes; b real time RT-PCR 
showed up-regulation of HMOX-1 protein expression following exposure to full flavor, and ULN CSEs; c western blot analyses of cellular membrane 
fractions corroborate with mRNA changes showing statistically significant up-regulation in protein expression; representative western blots were 
shown with actin as a loading control; d immunofluorescence analysis of HMOX1 expression. Data were expressed as mean ± SEM (fold change 
over control). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control. n = 6 biological replicates/condition.
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As shown in Figure  7a3, the cytoplasm/nuclear ratio of 
NFκB-p65 in BBB endothelial cultures exposed to 3R4F 
or ULN smoke extracts was only 50% of that measured in 
controls. By contrast, nicotine exposure alone did altered 
neither the mRNA expression nor the nuclear transloca-
tion of NFκB-p65 (Figure 7a1–a3).
Secretion of the pro-inflammatory cytokine interleukin 
8 (IL-8) and the chemokine Monocyte Chemoattract-
ant Protein-1 (MCP-1) are in agreement with NFκB-p65 
activation (Figure  7b). Both CSE from 3R4F and ULN 
cigarette products amplified the IL-8 secretory response 
by tenfold compared to control cultures (Figure  7b, 
p < 0.0001). Nicotine (100 ng/mL) was also found to sig-
nificantly elevate the release of IL-8 from BBB endothe-
lial cells (>2-fold), although the magnitude of nicotine’s 
effects was relatively very low when compared to CSEs 
(Figure  7b). In addition, release of vascular endothelial 
growth factor (VEGF), a known modulator of vascular 
angiogenesis, was also significantly increased in response 
to the exposure to 3R4F and ULN-derived CSE (Fig-
ure  7c, p  <  0.0001). Nicotine treatment alone was also 
found to induce the endothelial secretion of MCP-1 and 
VEGF by a marginal 1.5 fold over control (Figure 7b, c).
Discussion
The role of Nrf2 dependent antioxidant response pathway 
is well established in disorders aggravated by cigarette 
smoke such as lung emphysema, COPD, atherosclerosis 
and cardiac dysfunction [23–25]. In these disorders Nrf2 
deficiency has clearly been demonstrated to increase the 
susceptibility to cellular toxicity [26] and several natural 
and/or synthetic antioxidant based supplemental thera-
pies have proven to be beneficial in ameliorating the oxi-
dative damage [27, 28].
In this study we assessed the activity and biological 
responses of the human BBB endothelium to a number of 
biological factors related to Nrf2 activation. The endpoint 
goal of this work was to unravel (at a molecular level) the 
cause–effect relationship between the oxidative poten-
tial of full flavor (3R4F) and “reduced exposure” (ULN) 
tobacco products and the biological response of these 
cells.
Figure 7 CSE exposure of various TS products induces inflammatory stress in BBB ECs. a1 mRNA expression of NFκB-p65 in hCMEC/D3 cells fol-
lowing exposure to nicotine, CSE from both tobacco products; a2 western blot analysis of cytosolic and nuclear fractions of NFκB-p65 showed 
increased protein expression and nuclear localization following CSEs; representative western blots were shown with actin as a loading control; a3 
the translocation status could be better understood via ratio of cytosolic versus nuclear NFκB-p65 plotted in terms of percent control; b release 
of chemokines such as IL-8 and MCP-1 from hCMEC/D3 cell cultures as determined by ELISA; c VEGF release was up-regulated in endothelial 
cultures exposed to full flavor and ULN CSE but not nicotine. Data were expressed as mean ± SEM (fold change over control). *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001 vs. control. n = 6 biological replicates/condition.
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As expected the biological response of the BBB 
endothelium in respect to Nrf2 expression/activity sup-
ported our original hypothesis of a direct correlation 
between the oxidative potential of a tobacco product and 
its cellular toxicity. This is clearly shown in Figure 1 dem-
onstrating a striking relationship between oxidative stress 
generated by the CSE extracts on cultured endothelial 
cells (Figure  1a) and the effect on the expression level 
and nuclear translocation of Nrf2 in the same cells (Fig-
ure  1d). A data that already argue with the notion of 
“reduced exposure” tobacco product (such as ULN) being 
intrinsically less harmful than conventional cigarettes 
(such as 3R4F). Our results also indicate that cigarette 
reduction in nicotine content has a negligible or at best 
a very modest effect on the overall “safety” of the product 
itself in terms of oxidative damage to cells and tissues.
Nrf2-dependent anti-oxidant response is mainly 
divided into detoxification enzymes (such as Phase I—
oxidation/reduction, Phase II—conjugation enzymes and 
Phase III—efflux transporters) and anti-oxidant based 
system (such as glutathione and thioredoxin) [11]. As a 
follow up study, we performed transcriptome analysis to 
screen for the expression of several downstream targets 
of Nrf2-dependent antioxidant response. Nrf2 depend-
ent downstream genes were also highly up-regulated in 
response to CSE exposure whereas nicotine did not bear 
any significant effect. Specifically, a number of Phase I 
detoxification genes depending upon Nrf2/ARE path-
way activation were up-regulated including NQO1 (see 
also Additional file 1: Table  S1). NQO1 is a cytoplas-
mic 2-electron reductase that prevents the reduction of 
quinones and the resulting production of radical spe-
cies. NQO1 response to CSE exposure was observed at 
the gene expression, transcription and protein expres-
sion levels (see Figure  2). Taken together, we show that 
the both conventional and “reduced exposure” tobacco 
products (but not nicotine) elicit a strong oxidative stress 
response in BBB endothelial cells that well correlate with 
Nrf2 activation also elicited by CSE exposure.
Expression of Phase I Cytochrome P450s genes such 
as CYP2S1 and CYP51A1 were also up-regulated by 
exposure to CSE from both cigarette products although 
a corresponding increase in protein expression was not 
evident (see Figure  3). This could be possibly due to a 
longer time requirement for the gene expression changes 
to translate into measurable alteration of protein expres-
sion. Important to note however, is that very few stud-
ies have reported strong baseline expression of CYPs in 
normal BBB endothelium [29]. Thus, a distinct pattern 
of gene up-regulation of both CYP2S1 and CYP51A1 
which have been observed in response to TS detoxifica-
tion is a relevant piece of information further support-
ing the involvement of Nrf2 -dependent cytoprotection 
in response to TS exposure (see also Additional file 1: 
Table S2).
Another important component of BBB is the class of 
ABC transporters that function to efflux out both endog-
enous and exogenous toxicants out of the brain. As 
shown in Figure 4a, our data provides novel evidence of 
a potential augmentation of two classical ABCs, ABCA1 
(P-gp) and ABCC4 (MRP4) at the BBB in response to 
CSE exposure. These changes were tangible enough 
to show at the gene expression level however were too 
small to be detected to a significant level of confidence 
at the transcription and translation level. Nevertheless 
functional assessment of an assessment of functional 
efflux activity specifically for P-gp (measured via Rhoda-
mine-123; see also Figure  4c) clearly demonstrated sta-
tistically significant higher efflux function in EC cultures 
exposed to 3R4F. ULN effect was more modest. Con-
sidering that nicotine mildly down-regulated P-gp gene 
expression and did not affect its efflux activity, the differ-
ence between 3R4F and ULN in respect to P-gp activity 
can possibly reflect a difference in cigarette composition 
and substances released in solution which may differently 
affect P-gp expression. This provided a reasonable expla-
nation (although difficult to ascertain given the com-
plexity of cigarette composition) where again the total 
oxidative capacity of the TS product was the determining 
factor of cellular toxicity and activation of cytoprotec-
tive mechanisms. In addition to these major drug efflux 
transporters, gene array screening revealed up-regulation 
of several other ABC transporters primarily involved in 
cholesterol trafficking across the BBB (See also Addi-
tional file 1: Table S3).
The next level of cytoprotection provided by Nrf2-ARE 
pathway is the heightened synthesis of anti-oxidants such 
as GSH, thioredoxin. Exposure to CSE from 3R4F and 
ULN both elicited gene transcription and increase in the 
protein expression levels of the Cystine/glutamate trans-
porter antiporter SLC7A11 and the Glutamate cysteine 
ligase regulatory subunit  (also known as gamma-gluta-
myl cysteine synthetase) which is the first rate limiting 
enzyme of glutathione (GSH) synthesis (Figure  5a–c). 
Note, in fact, how the GSH//GSSG rate reflects the 
level of oxidative stress caused by TS exposure lead-
ing to GSH depletion (most evident in BBB endothelial 
cultures exposed to 3R4F; see Figure  5d). Note also the 
nicotine is capable in some measure to elicit oxidative 
stress. This is also reflected in the more modest but still 
significant decrease of GSH/GSSG ratio observed in BBB 
endothelial cells exposed to nicotine. Although the effect 
is relatively modest, this can explain while 3R4F exposure 
determined the most significant impact in terms of GSH 
reduction when compared to ULN product. ULN contain 
similar amount of TAR but negligible amount of nicotine. 
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In addition, concomitant up-regulation of several other 
genes related to NAPDH production were also observed. 
(See Additional file 1: Table S4). These genes function to 
recycle and regenerate the anti-oxidants back to the inac-
tive state [11].
Oxidative and inflammatory changes following TS 
exposure have been reported to elevate stress inducible 
enzyme HMOX-1 [30, 31]. Both 3R4F and ULN products 
showed comparable alterations in HMOX-1 (see Fig-
ure 6) and related genes (such as pirin, ferritin). Interest-
ingly, apart from metal chelation; pirin is also reported 
to govern the activation of NFκβ and its related genes 
via Nrf2 [21]. It is a non heme Fe protein that may func-
tion to sense redox stress for the NFκβ pro-inflammatory 
signalling and govern the expression of downstream 
genes involved in immune responses [21, 32, 33]. Ferri-
tin instead is a major intracellular storage protein which 
helps with iron homeostasis. It is usually composed of 
various ratios of light chain and heavy chain subunits. 
Following CSE treatment we observed increased tran-
scription of several of these subunits whereas, both 
3R4F and ULN products led to the activation of genes 
related to iron sequestration. In contrast, nicotine failed 
to induce any changes in gene and/or protein expression 
of HMOX-1. This again reiterated that the level of BBB 
toxicity was dependent on the oxidative and/or inflam-
matory capacity of the TS product which may not be dis-
criminated by the nicotine content alone.
Apart from Nrf2, another cell survival transcription 
factor reported in event of oxidative stress is nuclear fac-
tor kappa-light-chain-enhancer of activated B cells (NF-
κB); a protein complex that controls DNA transcription 
and is involved in cellular responses to harmful stimuli 
(including free radicals, pro-inflammatory cytokines, 
ultraviolet irradiation, etc.) and plays a key role in regu-
lating the immune and cell survival [22]. NFκB-p65 not 
only increased in total cytosolic levels, but also showed 
increased translocation into the nucleus (See Figure 7) in 
response to CSE exposure. Apart from classical activation 
of NFκβ in events of inflammatory/oxidative stress, Nrf1/
Nrf2 can up-regulate GCLC transcription indirectly via 
modulation of levels of NFκβ [34, 35]. Although based on 
current results we cannot assertively state if NFκB-p65 
was directly or indirectly activated; we observed a sig-
nificant increase of its nuclear translocation following 
CSE exposure. The effect was particularly enhanced in 
response to ULN-derived CSE; a cigarette product con-
sidered “reduced exposure” and less harmful than con-
ventional products. In addition, NFκβ-p65 expression 
and translocation patterns consistently paralleled stress 
fighting responses as reported in earlier observations. 
NFκβ activation typically involves either canonical or 
non-canonical pathways. The selection dependents on 
whether p50/p65 (RelA) (canonical) or p52/RelB (non-
canonical) is involved in the translocation and down-
stream activation. We could clearly observe increased 
translocation of the p65 sub unit into the nucleus indi-
cating activation of the canonical pathway and associated 
pro-inflammatory/cell survival responses. At this point, 
it is difficult assert if only this pathway was associated 
with the TS toxicity coping mechanisms; further stud-
ies will be required in future to specifically address this 
conundrum. Furthermore, we observed an increase of 
IL-8 release following both 3R4F and ULN-derived CSE 
exposures. In agreement with our findings, p65 sub unit 
was reported to activate IL-8 expression via promoter 
binding [36].
Interestingly, previous in vitro studies by Barr et al. [37] 
have shown a dose dependent nicotine-induced activa-
tion of stress-dependent NFkB pathway in mesencephalic 
cells. However, we observed only a marginal response to 
nicotine exposure (including NFκβ-p65 protein expres-
sion and nuclear translocation). A possible explanation of 
this discrepancy could be attributed to two factors: (1) for 
our experiments the reference concentration of nicotine 
used was approximately 0.6 µM which falls to the lower 
end of the concentrations tested by Barr and co-work-
ers; (2) time of assessment. In our study, oxidative stress 
measurements (as shown in Figure 1) were measured at 
3 h at which point we did note a slight increase of oxida-
tive stress in nicotine-exposed cultures versus controls. 
However, measurements of downstream effects such as 
NFkB-p65 activation (expression and nuclear transloca-
tion) were assessed at 24  h post exposure. It is possible 
that the oxidative stress effects elicited by nicotine fade 
off and became negligible at that time point.
As a part of vascular inflammation; cigarette-toxicity 
can lead to the up-regulation of several chemokines 
that promote cellular adhesion of white blood cells and 
facilitate their extravasation across the brain vasculature 
[38]. To understand the extent of vascular inflammation 
produced in the ECs following CSE exposure; we meas-
ured two major chemokines (IL-8 and MCP-1). Both 
these chemokines have been reported to be involved 
in the chemotaxis of neutrophils and monocytes after 
cigarette smoke exposure in lung and other periph-
eral vasculatures [39–41]. Release of IL-8 and MCP-1 
was significantly increased in BBB endothelial cultures 
exposed to CSE (both 3R4F and ULN). This is in agree-
ment with earlier published results by our group dem-
onstrating a number of inflammatory changes (including 
IL-6 release and up-regulation of vascular adhesion mol-
ecules such as VCAM-1, Pecam-1) in BBB ECs exposed 
to TS [8]. Finally, CSE from both 3R4F and ULN elicited 
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endothelial release of VEGF, a known modulator of vas-
cular angiogenesis released in response to hypoxic con-
dition and implicated in the alteration of BBB vascular 
integrity [42, 43].
Conclusion
In summary, this novel study provides a detailed under-
standing of Nrf2- related cytoprotective mechanisms 
activated in response to TS exposure and effectively cor-
relate them with their oxidative and inflammatory poten-
tial. Whole soluble components present in CSE and not 
nicotine seems to be the primary determinant of vascu-
lar toxicity. However, the identity of these specific com-
pounds remains still elusive. Given the extremely large 
number of compounds contained in cigarette smoke, the 
identification of the specific toxicant(s) (not necessar-
ily related to cancer genesis) responsible for the effects 
noted above (including potential synergistic and additive 
interactions) will be extraordinarily difficult to assess. In 
respect to our results as well as previous studies by our 
group and others, it is plausible that the oxidative stress 
stimuli generated by chronic TS exposure can effectively 
overwhelm the Nrf2 and NFκβ-dependent cytoprotec-
tive endothelial mechanisms. This can ultimately lead to 
impairment of BBB function and integrity thus promot-
ing cerebrovascular and CNS disorders. It is in fact well 
known that (1) chronic smokers suffer from antioxidant 
shortage (e.g., vitamin C and E) caused by increased anti-
oxidative mobilization in response to systemic oxidative 
stress evoked by ROS-enriched TS [44, 45]; (2) antioxi-
dant supplementation reduces the TS-dependent oxida-
tion and inflammation in animals and cells [10, 46]; (3) 
cigarette smoking facilitate the development of a pro-
atherosclerotic environment by inducing inflammation 
(recruitment of leukocytes through cytokine signaling 
[38–41, 47] and oxidation of low-density lipoprotein cho-
lesterol [7, 48]. Additional in vivo studies using direct 
inhalation models will be necessary to reveal the extent 
of the damage and risks associated with chronic tobacco 
smoking at the cerebrovascular level.
Methods
Materials and reagents
The antibodies used in this study were obtained from the 
following sources: Rabbit Nrf2 (#ab62352) from Abcam; 
rabbit MRP-4 (#12705S), mouse NQO1 (#3187), rab-
bit SLC7A11#12691, rabbit HMOX-1 #5061, NFkb p65 
#8242 from Cell Signaling Technology (Danvers, MA, 
USA); mouse GCLC #WH0002729M1, mouse GCLM 
#WH0002730M, rabbit CYP2S1 #SAB4501343, rabbit 
CYP51A1 (#C8873), β-actin #A5441 from Sigma-Aldrich 
(St. Louis, MO, USA); Mouse P-gp from Calbiochem 
(#517310); donkey anti-rabbit (#NA934) and sheep 
anti-mouse (#NA931) HRP-linked secondary antibod-
ies from GE  Healthcare (Piscataway, NJ, USA); mouse 
anti-claudin 5 (#35-2500), goat anti-rabbit (#A11008) 
and anti-mouse (#A21422) conjugated to Alexa Fluor® 
488 and 555 from Invitrogen (Camarillo, CA, USA). 
Sterile culture ware was obtained from Fisher Scientific 
(Pittsburgh, PA, USA), while other reagents and chemi-
cals were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) or Bio-rad laboratories (Hercules, CA, USA).
TS preparation
We followed a standardized ISO/FTC standard smok-
ing protocol (35  mL draw, 2  s puff duration, 1 puff per 
60 s), using a Single Cigarette Smoking Machine (SCSM, 
CH Technologies Inc., Westwood, NJ, USA) to pre-
pare our cigarette smoke extracts (CSE) as previously 
detailed elsewhere [8]. 8 puffs per cigarette were bubbled 
directly into phosphate buffered saline (PBS). Three ciga-
rettes per preparation were used to make 3× concentra-
tion (or 300%) stock solution which was then diluted to 
the desired concentration. Two types of cigarettes were 
used for this study: (a) full flavor cigarettes (3R4F, Uni-
versity of Kentucky) equivalent to conventional full flavor 
brands containing 9.4 mg tar and 0.726 mg nicotine per 
cigarette; (b) ultralow nicotine Spectrum cigarettes (from 
NIH/NIDA) equivalent to ultralow nicotine brands con-
taining 0.03 mg nicotine and 9 mg tar per cigarette. Tar 
content of these cigarettes is similar to that of 3R4F (full 
flavor product) but that of nicotine is negligible.
Cell culture
The hCMEC/D3 cells donated by Dr. Couraud (INSERM, 
Paris) (passage 29–30) were seeded on collagen coated 
cell culture flasks (2.0 × 104/cm2) and maintained at 37°C 
with 5% CO2 in EBM-2 basal medium (Lonza, Walk-
ersville, MD, USA) supplemented with 5% FBS (Atlanta 
Biologicals, Lawrenceville, GA, USA), Fibroblast Growth 
Factor (Sigma Aldrich Inc), chemically defined lipid con-
centrate (Life Technologies, Carlsbad, CA, USA), antibi-
otic/antimycotic (1:1, Atlanta Biologicals, GA, USA and 
HEPES (10 mM). Medium was changed once after 2 days 
and then every other day until cells formed a continuous 
confluent monolayer. BBB endothelial monolayers were 
then chronically exposed (3 times/24 h) to a final 5% CSE 
concentration [8] derived from freshly prepared smoke 
extracts diluted in EBM-2 culture media. Following CSE 
exposure cells were processed for RNA and protein col-
lection. Please note that a 5% CSE final concentration 
(using 3R4F cigarettes as reference) yields a nicotine out-
put of ≈100  ng/mL, which is comparable to the steady 
state blood nicotine concentration measured in an aver-
age chronic smoker (≈20 cigarettes/day) [8, 49–51]. 
Experiments related to nicotine exposure as a standalone 
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agent where performed by directly diluting nicotine in 
the culture media at the desired concentration (100 ng/
mL).
Microarray analysis
Total RNA was extracted using RNAeasy kit (Qiagen 
#74104) according to manufacturer’s instructions. The 
RNA concentration and purity was determined using 
Nanodrop ND-1000, before sending the samples Boston 
Children’s Hospital for further microarray analysis. A 
total of 100  ng of RNA was required for the hybridiza-
tion along with appropriate quality control (QC) samples. 
Illumina Human HT-12 expression bead chip was uti-
lized for the hybridization of samples on the chip (a total 
of 12 samples per chip). Raw data in the form of signal 
intensities for each gene probe were screened, filtered 
and converted into fold change values over control.
Real‑time PCR
RNeasy mini kit (Qiagen Inc, #74104) was used for the 
extraction of total RNA from BBB endothelial cell cul-
tures. Briefly, cells were lysed using RLT buffer and 
homogenized using a QIA shredder. The total RNA was 
then extracted from the lysate as per the manufacturer’s 
guidelines. Further, samples were analyzed by Nanodrop 
ND-1000 for quantity and purity (260/280 ratio close to 
1.9–2.1). A 20-μL first-strand cDNA synthesis reaction 
was performed using SuperScript III (Life Technologies, 
carlsbad, CA) and 5  μg of total RNA. 1μL of resulting 
cDNA was used in a PCR reaction of 25  μL contain-
ing 2 μL of each primer (10 μM). Primer pairs used in 
amplification have been detailed out in Additional file 1: 
Table  S5. Amplification was performed using a Bio-Rad 
CFX96 Touch™ Real-Time PCR detection system. The 
relative expression changes of the target genes i was then 
determined by ΔΔCt method [52], wherein target gene 
expression (based on Ct) was normalized against the 
house keeping gene (β-actin).
Western blotting
Proteins was collected and fractionated using Subcellu-
lar Protein Fractionation Kit for cultured cells (Thermo 
scientific, #78840) according to the manufacturer’s 
guidelines. Protein was quantified using Pierce BCA 
Protein Assay Kit (Thermo Scientific, #23225) and then 
denatured at 95°C for 5 min using sample buffer. Dena-
tured samples (15–20 μg) were subjected to SDS-PAGE 
(4–15% gradient gel) and then transferred to PVDF 
membranes (2  h transfer at 100  V) for further blotting. 
These PVDF membranes were blocked for 2 h using 5% 
non-fat dry milk in Tris buffered saline (TBS) contain-
ing 0.1% Tween-20 (TTBS) and subsequently incubated 
overnight with mouse (1:500) or rabbit (1:1,000) primary 
antibodies. This was followed by four TTBS washes 
(10 min each) and subsequent incubation with anti-rab-
bit or anti-mouse (1:10,000) HRP-conjugated secondary 
antibodies for 2  h. After four TTBS washes of 10  min 
each, the blots were developed using chemilumines-
cence detection method (using X-ray film based autora-
diography). Membranes were subsequently stripped and 
probed for other proteins. Ms β-actin (1:10,000) was used 
as a loading control. Band densities were analyzed by 
Licor Software, normalized to actin and expressed as fold 
change over control protein expression.
Immunofluorescence analysis
Cells were cultured in a two-well chamber slides for IFC 
analysis. Cells were fixed with 4% formaldehyde (15 min 
at 4°C) after period of 24 h. The slides were then washed 
with PBS, 5  min each for a total of three washes. This 
was followed by blocking with 5% goat serum (Sigma-
Aldrich, St. Louis, MO, USA) in PBS at room tempera-
ture for 50  min. Fixed cells were then incubated with 
primary antibodies (prepared in 5% GSA in PBS) at 4°C 
overnight. After PBS washes, cells were incubated for 1 h 
at RT with Alexa Fluor® 488 conjugated goat anti-rabbit 
or Alexa Fluor® 555 conjugated goat anti-mouse second-
ary (1:1000) antibodies. After three washes with PBS (of 
5  min each), cells were rinsed, air dried and mounted 
with DAPI in Prolonged Gold Anti-fade mounting media 
(Invitrogen, OR, USA). They were left for overnight dry-
ing in the dark before imaging with EVOS digital inverted 
fluorescence microscope. Cells stained with secondary 
antibodies alone were used as negative controls.
GSH/GSSG analysis
GSH/GSSG ratio in BBB endothelial cell cultures was 
determined using GSH/GSSG Ratio Detection Assay Kit 
(Fluorometric-Green) (Abcam Inc. #ab138881) according 
to the manufacturer’s guidelines. The samples were pre-
pared by lysis of total cell protein in T-PER lysis buffer 
followed by a dilution of 1:50 for GSH analysis. In brief, 
serial dilution of GSH and GSSG stock standards were 
prepared along with assay mixtures for detection of GSH 
and total GSH using 100× Thiol green stock solutions, 
assay buffer and GSSG probe. A one- step fluorimetric 
reaction of sample with respective assay buffers were 
incubated for 30  min. Fluorescence intensity was then 
monitored at Ex/Em of 490/520  nm. GSSG was deter-
mined by subtracting GSH from total GSH. Finally ratio 
of GSH was plotted against GSSG to obtain the GSH 
activity.
Statistical analyses
Data from microarray as well as proteomic studies were 
expressed as fold changes over control ± standard error 
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of mean (SEM). The data from all four groups were ana-
lyzed by t test or one-way ANOVA using GraphPad 
Prism Software Inc. (La Jolla, CA, USA). Post hoc mul-
tiple comparisons were conducted using Tukey’s test. P 
values ≤0.05 were considered statistically significant.
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